Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Treating Pharma Data as an Asset: moving from an application centric to an information-centric organization – presented by Dr. Martin Romacker, Roche

Posted on July 14th, 2020 by

Pharma knows there is a need for clean, reusable, FAIR data to fuel effective machine learning-driven R&D – but driving effective information and knowledge management is a long process, needing a step change where individuals learn their roles in data stewardship and reduce them to practice in a way that doesn’t constrain or impede their research activities.

(more…)

The Dawn of a European Health Data Space – Opportunities

Posted on July 9th, 2020 by

At the beginning of 2020, the European Commission introduced a “European strategy for data.” The document proposes to bolster and advance the data economy in Europe with a view towards capturing “the benefits of better use of data, including greater productivity and competitive markets, but also improvements in health and well-being, environment, transparent governance and convenient public services.”

(more…)

A Novelty Metric for Evaluating Journal Articles and Authors

Posted on July 7th, 2020 by

Scientists have long looked for ways to measure the impact and value of their research. In this article we propose a new metric that attempts to measure the recency of the facts discussed in an article.

(more…)

Readying Your Workforce for Digital Transformation

Posted on June 23rd, 2020 by

Seeing it as key to innovation and competitive advantage, many businesses in the life sciences are learning to embrace digital transformation these days—in fact, with good reason, most view it as necessary for survival. But whether or not the process of adopting rapidly-evolving digital-age technologies will actually result in business success can really depend on how you do it.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 84